Institutional Ownership T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX). We have compiled data on the 80 institutions that hold shares in the stock, with a total of 37.8 Million shares, which have been reported (via 13F filing form) to have a value of $72.6 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ever Source Wealth Advisors, LLC
|
Aug 13, 2025 Q2 2025 |
70
shares
|
$130
0.0% of portfolio
|
Q2 2025
Added 233.33%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
69
shares
|
$128
0.0% of portfolio
|
Q2 2025
Reduced 93.81%
|
|
|
True Wealth Design, LLC
Akron, OH |
Aug 06, 2025 Q2 2025 |
42
shares
|
$78
0.0% of portfolio
|
Q2 2025
Added 27.27%
|
|
|
Atlas Capital Advisors LLC
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
18
shares
|
$33
0.0% of portfolio
|
Q1 2024
Reduced 97.99%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|